Literature DB >> 19734842

Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.

Mahmoud Goodarzi1, Arlene M Correa, Jaffer A Ajani, Stephen G Swisher, Wayne L Hofstetter, Sushovan Guha, Michael T Deavers, Asif Rashid, Dipen M Maru.   

Abstract

The high interobserver variability in grading dysplasia in Barrett's esophagus demands a biomarker that can be applied in routine surgical pathology practice. Immunohistochemistry for phosphorylated histone H3 is a reliable marker of identifying mitotic figures and has not been evaluated in Barrett's esophagus-associated neoplastic lesions. We retrospectively studied the expression of phosphorylated histone H3 in 88 endoscopic biopsy samples of Barrett's esophagus without dysplasia (n=19), indefinite for dysplasia (n=11), low-grade dysplasia (n=27), high-grade dysplasia (n=19), or adenocarcinoma (n=12) from a sample of 54 patients. The samples were included after consensus diagnosis of two gastrointestinal pathologists on the hematoxylin-eosin (HE)-stained sections. Anti-phosphorylated histone H3-labeled mitotic figures were counted per 10 consecutive high-power fields (HPFs) in three distinct regions: surface epithelium, upper 2/3, and lower 1/3 of the crypts. Anti-phosphorylated histone H3-labeled mitotic counts for the three compartments of the crypts and the total scores for Barrett's esophagus, indefinite for dysplasia, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma were compared using the Mann-Whitney U test. For each compartment, the number of anti-phosphorylated histone H3-positive nuclei was higher in low-grade dysplasia than in Barrett's esophagus without dysplasia or indefinite for dysplasia (P<0.001), but no difference was found between Barrett's esophagus without dysplasia and indefinite for dysplasia. High-grade dysplasia biopsies had significantly more anti-phosphorylated histone H3-labeled mitotic figures in the surface epithelium than the low-grade dysplasia (P<0.001). Adenocarcinoma had higher anti-phosphorylated histone H3-labeled mitotic figures than the high-grade dysplasia (P<0.001). Our data support the previous findings of expansion of the proliferative zone and importance of surface mitotic figure in the progression of Barrett's esophagus-low-grade dysplasia-high-grade dysplasia. In addition, phosphorylated histone H3 is a potential supportive marker to histology in differentiating low-grade dysplasia from indefinite for dysplasia and high-grade dysplasia from adenocarcinoma in the mucosal biopsy samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734842     DOI: 10.1038/modpathol.2009.133

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  2 in total

Review 1.  [Intraepithelial neoplasia of Barrett's esophagus: prognosis of potential malignancy].

Authors:  M Werner; S Lassmann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

2.  Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.

Authors:  Zhimin Tong; Devkumar Chatterjee; Defeng Deng; Omkara Veeranki; Alicia Mejia; Jaffer A Ajani; Wayne Hofstetter; Steven Lin; Sushovan Guha; Scott Kopetz; Sunil Krishnan; Dipen Maru
Journal:  Oncotarget       Date:  2017-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.